Healthcare Sector

LLY

Market Tracker

$884.11
-33.54
(-3.65%)
2:40 am
Next Earnings: (est.) 08/08/23 12:00 am
  • LLY (Selected)

    Eli Lilly and Company
  • LLYVA

  • LLYVK

  • LLYX

LLY Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

LLY Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

LLY Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

LLY Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

LLY Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

LLY Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
05/01/2026 CALL $1,250.00 1,070 +982 +1,115.91%
05/01/2026 CALL $1,400.00 688 +404 +142.25%
04/24/2026 CALL $950.00 1,462 +354 +31.95%
05/08/2026 PUT $890.00 426 +332 +353.19%
06/18/2026 PUT $400.00 414 +263 +174.17%
04/24/2026 PUT $830.00 982 +252 +34.52%
05/15/2026 CALL $1,100.00 676 -53 -7.27%
07/17/2026 PUT $840.00 674 -58 -7.92%
06/18/2026 CALL $1,000.00 1,477 -60 -3.90%
05/15/2026 PUT $960.00 193 -100 -34.13%
05/15/2026 PUT $1,100.00 48 -100 -67.57%
04/24/2026 PUT $880.00 602 -162 -21.20%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

LLY Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.74% 26M 11.45B
Vanguard 500 Index Fund 1.92% 18.23M 8.03B
Vanguard/Primecap Fund 1.56% 14.85M 6.54B
Fidelity 500 Index Fund 0.91% 8.65M 3.81B
SPDR S&P 500 ETF Trust 0.90% 8.54M 3.76B
Vanguard Specialized-Health Care Fund 0.80% 7.64M 3.37B
iShares Core S&P 500 ETF 0.74% 7.04M 3.1B
Washington Mutual Investors Fund 0.73% 6.95M 3.06B
Growth Fund Of America Inc 0.71% 6.7M 2.95B
Select Sector SPDR Fund-Health Care 0.67% 6.41M 2.82B

LLY News

  • Should You Add a Healthcare Stock to Your Portfolio This Month? And Should It Be Eli Lilly (LLY)?

    04/25 07:05 pm

    The Motley Fool

    Read more
  • Is This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom?

    04/25 01:05 pm

    The Motley Fool

    Read more
  • Why Eli Lilly Stock Flopped on Friday

    04/24 06:30 pm

    The Motley Fool

    Read more
  • Deal Dispatch: QXO Nabs TopBuild For $17 Million, Voya Financial Urged To Evaluate Strategic Options, Pat McGrath Exits Chapter 11

    04/24 02:27 pm

    Benzinga

    Read more
  • Radiopharmaceuticals Market Size to Exceed USD 15.21 Billion By 2035 Rising Cancer Cases Boost the Market Demand

    04/24 09:57 am

    GlobeNewswire Inc.

    Read more
  • Hims & Hers Positions Itself As Supply Anchor In Hormone Therapy Crunch

    04/23 12:19 pm

    Benzinga

    Read more
  • Kailera Therapeutics' Strong IPO Validates "NewCo" Strategy

    04/23 12:08 pm

    Benzinga

    Read more
  • Is Novo Nordisk's 72% Crash a Generational Buying Opportunity or a Value Trap?

    04/23 09:30 am

    The Motley Fool

    Read more
  • Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins

    04/23 05:30 am

    The Motley Fool

    Read more
  • 3 Healthcare Stocks With the Most Durable Competitive Moats

    04/23 04:05 am

    The Motley Fool

    Read more
  • Large Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges

    04/22 02:20 pm

    Benzinga

    Read more
  • Why Did Eli Lilly Stock Drop Today?

    04/21 10:35 am

    The Motley Fool

    Read more
  • A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly

    04/21 07:30 am

    The Motley Fool

    Read more
  • Why Legend Biotech Stock Crushed the Market on Monday

    04/20 06:16 pm

    The Motley Fool

    Read more
  • Will Eli Lilly's New GLP-1 Pill Get the Stock Get Back to a $1 Trillion Valuation?

    04/20 10:15 am

    The Motley Fool

    Read more
  • This Drug Stock Has Crushed the S&P 500 Over the Last Decade

    04/18 05:15 pm

    The Motley Fool

    Read more
  • Deal Dispatch: Amazon Buys Globalstar, Instacart Grabs Instaleap, QVC Announces Bankruptcy

    04/17 02:33 pm

    Benzinga

    Read more
  • Kailera Therapeutics Debut Marks Largest Biotech IPO Since 2021 Amid Weight Loss Race

    04/17 01:23 pm

    Benzinga

    Read more
  • Novo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake

    04/17 12:04 pm

    Benzinga

    Read more
  • China Diabetes Devices Market Forecast and Company Analysis Report 2026-2034 Featuring Roche, Abbott Laboratories, Novo Nordisk, BD, Medtronic, Eli Lilly, and Sanofi

    04/17 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Is Viking Therapeutics the Ultimate Millionaire-Maker Obesity Stock for 2026?

    04/17 05:10 am

    The Motley Fool

    Read more
  • Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight

    04/16 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson

    04/16 10:16 am

    Benzinga

    Read more
  • Is This $6.3 Billion Deal a Game Changer for Eli Lilly?

    04/16 09:30 am

    The Motley Fool

    Read more
  • Eli Lilly's New Oral Weight Loss Drug Clears Cardiovascular Bar

    04/16 08:39 am

    Benzinga

    Read more
  • Prediction: This 1 Thing Could Cement Eli Lilly's Leadership in the Billion-Dollar Weight Loss Drug Market

    04/16 04:08 am

    The Motley Fool

    Read more
  • The $1 Trillion Race: Why Eli Lilly Is Leaving Novo Nordisk in the Dust

    04/15 01:26 pm

    The Motley Fool

    Read more
  • GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market

    04/15 01:25 pm

    Benzinga

    Read more
  • Eli Lilly's Jaypirca Builds Case With Fourth Positive Phase 3 Trial In Blood Cancer Patients

    04/13 09:29 am

    Benzinga

    Read more
  • Dementia Market Insight, Epidemiology, and Forecasts, 2022-2025 & 2026-2034

    04/13 04:59 am

    GlobeNewswire Inc.

    Read more
  • Here's Why Buying This Vanguard Index Fund Today Could Be the Best Financial Decision You Ever Make

    04/10 03:15 pm

    The Motley Fool

    Read more
  • Atopic Dermatitis (7MM) Drug Market Forecast and Analysis Report 2023-2033: Opportunities Remain for the Treatment of AD, Novel Systemic Therapies Dominate the Late-stage Pipeline

    04/10 04:52 am

    GlobeNewswire Inc.

    Read more
  • Atopic Dermatitis 68-Market Drug Forecast and Market Analysis Report 2023-2025 & 2025-2033

    04/10 04:46 am

    GlobeNewswire Inc.

    Read more
  • Crohn's Disease Eight-Market Drug Forecast and Market Analysis Report 2025-2026: Novel MOAs Will Provide Market Shifts Throughout the Forecast Period to 2032

    04/10 04:43 am

    GlobeNewswire Inc.

    Read more
  • Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting

    04/09 07:00 am

    GlobeNewswire Inc.

    Read more
  • Eli Lilly Faces Pressure In India As Cheaper GLP-1 Rivals Dent Mounjaro Sales

    04/09 06:44 am

    Benzinga

    Read more
  • Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model

    04/09 02:00 am

    GlobeNewswire Inc.

    Read more
  • Nxera Pharma Achieves Second Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases

    04/08 07:34 pm

    GlobeNewswire Inc.

    Read more
  • ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event

    04/08 04:00 pm

    GlobeNewswire Inc.

    Read more
  • Looks Like M&A Week in 3 Different Sectors

    04/08 12:02 pm

    The Motley Fool

    Read more
  • Incyclix Bio Raises Additional $5 Million in Series B Financing to Advance Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors

    04/08 07:00 am

    GlobeNewswire Inc.

    Read more
  • AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly

    04/07 07:00 am

    GlobeNewswire Inc.

    Read more
  • Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won’t Pay a Dime

    04/06 01:20 pm

    Investing.com

    Read more
  • Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight

    04/04 01:32 pm

    The Motley Fool

    Read more
  • Why Novo Nordisk's Pricing Shift Could Unlock a Much Larger Obesity Market

    04/03 05:02 pm

    The Motley Fool

    Read more
  • Where Will Viking Therapeutics Stock Be in 10 Years?

    04/03 03:26 pm

    The Motley Fool

    Read more
  • Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy

    04/03 10:35 am

    Benzinga

    Read more
  • Dow, S&P 500, Nasdaq: From Morning Meltdown to Midday "Meh"

    04/02 02:25 pm

    The Motley Fool

    Read more
  • Lilly’s Next Empire: A $10 Billion Bet on AI and Neuroscience

    04/02 01:51 pm

    Investing.com

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: